Introduction
Maxxtol is a medication that contains the active ingredient Tolfenamic Acid. It is available in injectable form and is primarily used to provide relief from pain and inflammation associated with various conditions.
Uses
Maxxtol is commonly prescribed for the management of pain and inflammation in conditions such as musculoskeletal disorders, acute gouty arthritis, postoperative pain, and dental pain. It is also used to alleviate menstrual pain and discomfort.
Dosage and Administration
The dosage of Maxxtol may vary depending on the specific condition being treated and the individual patient’s response. It is typically administered by a healthcare professional through injection into a muscle or vein.
The recommended initial dose for adults is usually 40 to 80 mg, given as a single injection. This may be followed by additional doses if necessary, with a maximum daily dose of 160 mg. The dosage for children should be determined by a healthcare professional based on their age, weight, and medical condition.
Mechanism of Action
Tolfenamic Acid, the active ingredient in Maxxtol, belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain substances in the body that are responsible for pain and inflammation. This helps to reduce pain, swelling, and stiffness associated with various conditions.
Side Effects
Common side effects may include nausea, vomiting, stomach pain, diarrhea, dizziness, and headache. These side effects are usually mild and transient.
However, some individuals may experience more serious side effects, such as allergic reactions, gastrointestinal bleeding, kidney problems, and liver damage. If you experience any severe or persistent side effects, seek medical attention immediately.
Drug Interactions
Maxxtol may interact with other medications, including blood thinners, antihypertensives, diuretics, and certain other NSAIDs. These interactions can increase the risk of side effects or affect the efficacy of either medication. Inform your healthcare provider about all medications you are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.
Precautions
Before using Maxxtol, inform your healthcare provider about any known allergies, medical conditions, or medications you are currently taking. This medication should be used with caution in individuals with a history of stomach ulcers, bleeding disorders, heart disease, kidney disease, or liver disease.
Maxxtol is contraindicated in individuals with a known hypersensitivity to Tolfenamic Acid or any other components of the medication. It should not be used during pregnancy or breastfeeding unless specifically prescribed by a healthcare professional.
Storage
Maxxtol should be stored at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has passed the expiration date or if the solution appears discolored or contains particles.
Patient Tips
- Follow the dosage instructions provided by your healthcare provider.
- If you miss a dose, contact your healthcare provider for guidance.
- Inform your healthcare provider if you experience any new or worsening symptoms while using Maxxtol.
- Avoid consuming alcohol while taking this medication, as it may increase the risk of side effects.
- If you have any concerns or questions about the medication, consult your healthcare provider for clarification.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Isovaleric acidaemia (NHS UK) [Accessed 15 Jun. 2024] (online) Available at:
- Clotam Rapid (Health Professionals SmPC) Available at:
- Tolfenamic Acid (International database) (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
- Ahmed S, Sheraz MA, Ahmad I. Tolfenamic Acid. Profiles Drug Subst Excip Relat Methodol. 2018;43:255-319. doi: 10.1016/bs.podrm.2018.01.001. Epub 2018 Mar 16. [Accessed 14 Jun. 2024] Available at:
Reviews
There are no reviews yet.